Skip to main content

Type II minocycline-induced cutaneous and scleral hyperpigmentation

This is a preview of subscription content, access via your institution.

Fig. 1


  1. 1.

    Basler RS (1985) Minocycline-related hyperpigmentation. Arch Dermatol 121:606–608

    CAS  Article  Google Scholar 

  2. 2.

    Dominic MR (2020) Adverse reactions induced by minocycline: a review of literature. Curr Drug Saf 16:1–13.

    Article  Google Scholar 

  3. 3.

    Geria AN, Tajirian AL, Kihiczak G, Schwartz RA (2009) Minocycline-induced skin pigmentation: an update. Acta Dermatovenerol Croat 17:123–126

    PubMed  Google Scholar 

  4. 4.

    Mouton RW, Jordaan HF, Schneider JW (2004) A new type of minocycline-induced cutaneous hyperpigmentation. Clin Exp Dermatol 29:8–14

    CAS  Article  Google Scholar 

Download references

Author information



Corresponding author

Correspondence to Zaw Min.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Human and animal rights

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. This article does not contain any studies with animals performed by any of the authors.

Informed consent

Informed consent was obtained from all individual participants included in the study.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Min, Z., Saini, V., Mount, C.E. et al. Type II minocycline-induced cutaneous and scleral hyperpigmentation. Intern Emerg Med (2021).

Download citation